CVB homepage

Trending
CT-FFR standardized in new SCCT-SCAI consensus statement
How to evaluate risk when TAVR patients require surgery later in life
Former ACC president William Parmley remembered as powerhouse in cardiology
FDA highlights recall of certain Impella introducer kits after 3 injuries
New-look pacemaker uses ultrasound to stimulate the heart—no implant required
DDR dynamic cardiac X-ray for pulmonary valve regurgitation evaluation. Figure courtesy of RSNA
Seven-second X-ray assesses severity of regurgitation congenital heart defect patients

Moving X-ray images can help evaluate pulmonary regurgitation in Tetralogy of Fallot patients.

Cathie Biga, MSM, MACC, past president of the American College of Cardiology (ACC) and president/CEO of Cardiovascular Management of Illinois, spoke in a business session at ACC 2026 on the use of artificial intelligence analytics and said human interface is needed to make the data actionable.
The key to AI cardiology analytics is human action

While AI analytics has greatly increased the ease of access to vast amounts of cardiology data, action is still required to make it useful.
 

U.S. Supreme Court, SCOTUS. Photo by Dave Fornell
U.S. Supreme Court sides with generic drug maker for severe hypertriglyceridemia agent icosapent ethyl

The decision clears the way for Hikma Pharmaceuticals' sale of icosapent ethyl in the U.S. market.

12-lead ECG EKG GE MAC VU360 ACC24.
AI detection of cardiac amyloidosis on ECG granted patent

This could enable ECG to become a primary screening tool for a largely underdiagnosed cardiac disease.

The Edwards Lifesciences Triformis Resilia surgical tricuspid valve top and side views..
FDA clears first dedicated tricuspid surgical valve

The Edwards Lifesciences Triformis Resilia is the first dedicated surgical tricuspid valve on the market cleared with data from off-label use of mitral valves.

Michael Coords, MD, FSCCT, Medical Director of Cardiovascular Imaging, RadNet, a leader with the SCCT Health Policy and Practice Committee Regulatory Task Force, and incoming co-chair of the Health Policy and Practice Committee, says SCCT offers a unique blend of clinical education, business strategy, and networking to stay on top of CCTA's rapid proliferation.
Radiologists: Take the deep dive into advanced cardiovascular CT at SCCT

SCCT offers a unique blend of clinical education, business strategy, and networking to stay on top of CCTA's rapid proliferation.

Ronen Rubinshtein, MD, FACC, FESC, director, heart institute, Edith Wolfson Medical Center, in Holon, Israel, president elect for the Society of Cardiovascular Computed Tomography (SCCT), and chairman of the SCCT 2026 annual scientific meeting, explains plaque imaging, AI and structural heart disease are the spotlight at the meeting.
Plaque imaging, AI and structural heart disease in the spotlight at SCCT 2026 meeting

Coronary plaque imaging is an area many experts believe is driving a shift toward earlier detection and prevention of heart disease.

A figure from the new SCCT FFR-CT consensus document to help explain how the technology works to assess hemodynamic flow using CT imaging.
CT-FFR standardized in new SCCT-SCAI consensus statement

FFR-CT literature has reached a state of maturity where experts can comfortably start to provide guidelines to the wider community. 

Robert Hawkins, MD, MSC, assistant professor of cardiac surgery, University of Michigan, discusses the growing trends of surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR) and how to best risk assess these patients using a new STS risk calculator.
How to evaluate risk when TAVR patients require surgery later in life

Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business.

Innovation at work

Cardiovascular Business
Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx

Around the web

Health Exec
Hospital execs exhorted to lead the affordability movement from the front
Radiology Business
‘Disaster for research’: Concern among radiologists over new federal rule regulating grantmaking
Radiology Business
University of Utah names new radiology chair